Dubai extradites Denis Dizdari after 10-year Belgian sentence, testing UAE pharmacy controls

Denis Matoshi, also known as Denis Dizdari, has been extradited from the United Arab Emirates to Belgium and placed in a Belgian prison after a 10-year sentence in Antwerp, according to Balkanweb on 2 October 2026.

For UAE healthcare operators, the case is less about street narcotics than about pharmacy trust. Dubai clinics, pharmacies and insurers need clean controlled-medicine records because patient access to legitimate medicines depends on regulators being able to separate licensed supply from criminal logistics. In Dubai, the relevant regulator is the Dubai Health Authority (DHA). In Abu Dhabi and Al Ain it is the Department of Health Abu Dhabi (DOH). In Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain it is the Ministry of Health and Prevention (MOHAP), with medicines registration functions now tied to the Emirates Drug Establishment.

What Belgian authorities say

Balkanweb reported that Dizdari, aged 37, was linked by Belgian authorities to the Albanian criminal organisation Kompania Bello and to the Yaramis drug-trafficking case. The Antwerp court sentence cited by Balkanweb included 10 years in prison, an €80,000 fine and a confiscation order of €7.5 million in alleged criminal proceeds attributed to him.

The report said Dizdari had lived in Dubai for years and was arrested in the UAE about two years ago after a Belgian extradition request. Belgian prosecutors alleged the group organised cocaine removals from Antwerp port piers 1700 and 1742. Balkanweb also reported that separate Sky ECC communications referred to €1.75 million in cash transfers during 2020 and 2021; that part of the case is due to be examined later.

Cooperation with the United Arab Emirates shows that there are no safe havens for drug criminals.
Annelies Verlinden, Belgian Justice Minister, as reported by Balkanweb

Why this matters to UAE pharmacy operators

The immediate compliance lesson sits with COOs, pharmacy directors and payer fraud teams. DHA says its Drug Control function governs medicine processes according to Emirates Drug Establishment classifications, including controlled, semi-controlled, narcotic, prescription-only and general medicines. That makes controlled-medicine documentation a board-level risk for multi-site clinic groups and pharmacies.

In Abu Dhabi, DOH Circular 2024/112, dated 16 July 2024, required all healthcare and pharmaceutical facilities and pharmacists to register for the National Platform for Narcotic and Controlled Medicines and to use the inventory module from 15 July 2024. DOH said non-compliance constitutes a violation that can trigger disciplinary action under applicable legislation.

For insurers such as Daman, Thiqa and Sukoon, the operational issue is claims quality. A controlled or semi-controlled medicine claim should reconcile the prescriber, facility licence, patient eligibility, diagnosis code, refill interval and medicine registration status. A mismatch is a payment risk and a patient-safety risk. For patients, the practical point is simpler: buy prescription and controlled medicines only through licensed pharmacies and keep prescriptions, Emirates ID details and travel documents aligned.

What to check this week

Operators should use official registers rather than supplier screenshots or social-media price claims. The Emirates Drug Establishment drug directory shows registered product status and had a listed dataset refresh of 10 September 2026 when accessed by Zavis. If a pharmacy team needs a price, it should check the product in the official directory or request the applicable price list through the regulator channel. Product-level prices vary by active ingredient, dosage, pack size and agent, so an unverifiable AED range is a bad control.

• Dubai providers should confirm DHA licence status for each pharmacy site and pharmacist handling controlled medicines.
• Abu Dhabi and Al Ain providers should verify National Platform registration and inventory use from 15 July 2024.
• Northern Emirates providers should keep MOHAP licence records and EDE product-registration checks in the dispensing file.
• Payers should audit high-risk pharmacy claims by product, prescriber, refill timing and patient eligibility.
• Patients carrying controlled medicines into the UAE should check MOHAP rules; published UAE guidance refers to a maximum of three months of personal medical need for narcotic and psychotropic medicines.

The extradition does not imply a failure by UAE healthcare providers. It does show why pharmacy governance is now part of wider financial-crime and patient-safety scrutiny. For a practical starting point, use the UAE Open Healthcare Directory to find licensed pharmacy providers; Zavis lists 12,390+ licensed UAE healthcare providers, including pharmacy categories across Dubai, Abu Dhabi, Al Ain and the northern emirates.